申请人:SAKAGAMI Masahiro
公开号:US20120130070A1
公开(公告)日:2012-05-24
This invention provides a compound of the formula (I):
a pharmaceutically acceptable salt or solvate thereof, wherein
R
1
is substituted or unsubstituted alkyl or the like,
R
2
is hydrogen or substituted or unsubstituted alkyl,
Ring A is monocyclic or bicyclic aromatic heterocycle,
R
3
is substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl or substituted or unsubstituted heterocycle,
R
4
is halogen, cyano, substituted or unsubstituted alkyl, substituted or unsubstituted cycloalkyl or the like,
m is an integer between 0 and 2,
n is an integer between 0 and 5,
R is halogen, oxo, cyano, nitro, substituted or unsubstituted alkyl or the like, and
p is an integer between 0 and 2
as novel compounds having NPY Y5 antagonistic activity.